Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017

Fig. 4

Factors limiting respondents’ pharmacological thromboprophylaxis use (Study 1 N = 221, Study 2 N = 301); *added in 2017. Legend: Inpatient and Discharge pharmacological prophylaxis use (Study 1); Inpatient and Discharge aspirin use (Study 2); Inpatient and Discharge anticoagulant use (Study 2). Total proportion of surgeons who answered the question in and

Back to article page
\